IGC Pharma (IGC) FCF Margin Growth (5y) (2015 - 2025)
Powered by 
Analysis
IGC Pharma (IGC) FCF Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 147,980.00 |
| Jun 30, 2025 | 51,580.00 |
| Mar 31, 2025 | 910,782.00 |
| Dec 31, 2024 | 15,174.00 |
| Sep 30, 2024 | -11,435.00 |
| Jun 30, 2024 | -41,279.00 |
| Mar 31, 2024 | -10,842.00 |
| Dec 31, 2023 | -70,738.00 |
| Sep 30, 2023 | -52,908.00 |
| Jun 30, 2023 | -23,171.00 |
| Mar 31, 2023 | -82,203.00 |
| Dec 31, 2022 | -62,602.00 |
| Sep 30, 2022 | -58,775.00 |
| Jun 30, 2022 | -10,232.00 |
| Mar 31, 2022 | 19,855.00 |
| Dec 31, 2021 | -175,243.00 |
| Sep 30, 2021 | -362,456.00 |
| Jun 30, 2021 | -259,393.00 |
| Mar 31, 2021 | -318,178.00 |
| Dec 31, 2020 | -184,431.00 |